84 related articles for article (PubMed ID: 12183060)
41. The urokinase plasminogen activator system in breast cancer invasion and metastasis.
Tang L; Han X
Biomed Pharmacother; 2013 Mar; 67(2):179-82. PubMed ID: 23201006
[TBL] [Abstract][Full Text] [Related]
42. The cleavage of pro-urokinase type plasminogen activator by stromelysin-1.
Orgel D; Schröder W; Hecker-Kia A; Weithmann KU; Kolkenbrock H; Ulbrich N
Clin Chem Lab Med; 1998 Sep; 36(9):697-702. PubMed ID: 9804393
[TBL] [Abstract][Full Text] [Related]
43. Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence.
Chiaradonna F; Fontana L; Iavarone C; Carriero MV; Scholz G; Barone MV; Stoppelli MP
EMBO J; 1999 Jun; 18(11):3013-23. PubMed ID: 10357814
[TBL] [Abstract][Full Text] [Related]
44. A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.
Liu D; Zhou D; Wang B; Knabe WE; Meroueh SO
ACS Chem Biol; 2015 Jun; 10(6):1521-34. PubMed ID: 25671694
[TBL] [Abstract][Full Text] [Related]
45. Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility.
Franco P; Iaccarino C; Chiaradonna F; Brandazza A; Iavarone C; Mastronicola MR; Nolli ML; Stoppelli MP
J Cell Biol; 1997 May; 137(3):779-91. PubMed ID: 9151681
[TBL] [Abstract][Full Text] [Related]
46. Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation.
Conese M; Blasi F
Biol Chem Hoppe Seyler; 1995 Mar; 376(3):143-55. PubMed ID: 7612191
[TBL] [Abstract][Full Text] [Related]
47. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
Pass J; Jögi A; Lund IK; Rønø B; Rasch MG; Gårdsvoll H; Lund LR; Ploug M; Rømer J; Danø K; Høyer-Hansen G
Thromb Haemost; 2007 Jun; 97(6):1013-22. PubMed ID: 17549305
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: activation of plasminogen activator inhibitor 1 expression.
Lee H; Struman I; Clapp C; Martial J; Weiner RI
Endocrinology; 1998 Sep; 139(9):3696-703. PubMed ID: 9724020
[TBL] [Abstract][Full Text] [Related]
49. Production of plasminogen activators (PAs) in bovine cumulus-oocyte complexes during maturation in vitro: effects of epidermal growth factor on production of PAs in oocytes and cumulus cells.
Park KW; Choi SH; Song XX; Funahashi H; Niwa K
Biol Reprod; 1999 Jul; 61(1):298-304. PubMed ID: 10377062
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.
Moriwaki H; Stempien-Otero A; Kremen M; Cozen AE; Dichek DA
Circ Res; 2004 Sep; 95(6):637-44. PubMed ID: 15297377
[TBL] [Abstract][Full Text] [Related]
51. Upregulation of urokinase in alveolar macrophages and lung tissue in response to silica particles.
Lardot C; Delos M; Lison D
Am J Physiol; 1998 Jun; 274(6):L1040-8. PubMed ID: 9609744
[TBL] [Abstract][Full Text] [Related]
52. Characterization of a plasminogen activator produced by Acanthamoeba castellanii.
Mitra MM; Alizadeh H; Gerard RD; Niederkorn JY
Mol Biochem Parasitol; 1995 Jul; 73(1-2):157-64. PubMed ID: 8577323
[TBL] [Abstract][Full Text] [Related]
53. Species specificity of amidine-based urokinase inhibitors.
Klinghofer V; Stewart K; McGonigal T; Smith R; Sarthy A; Nienaber V; Butler C; Dorwin S; Richardson P; Weitzberg M; Wendt M; Rockway T; Zhao X; Hulkower KI; Giranda VL
Biochemistry; 2001 Aug; 40(31):9125-31. PubMed ID: 11478879
[TBL] [Abstract][Full Text] [Related]
54. Effect of tethered peptidylchloromethylketone inhibitors on thermal stability and domain interactions of urokinase and other serine proteases.
Novokhatny VV; Medved LV; Mazar A; Ingham KC
J Biol Chem; 1993 Aug; 268(23):17211-8. PubMed ID: 8349606
[TBL] [Abstract][Full Text] [Related]
55. Interferon activates macrophages to produce plasminogen activator.
Jones CM; Varesio L; Herberman RB; Pestka S
J Interferon Res; 1982; 2(3):377-86. PubMed ID: 6890086
[TBL] [Abstract][Full Text] [Related]
56. Actinin-4 is preferentially involved in circular ruffling and macropinocytosis in mouse macrophages: analysis by fluorescence ratio imaging.
Araki N; Hatae T; Yamada T; Hirohashi S
J Cell Sci; 2000 Sep; 113 ( Pt 18)():3329-40. PubMed ID: 10954430
[TBL] [Abstract][Full Text] [Related]
57. Irreversible inhibition of serine proteases - design and in vivo activity of diaryl alpha-aminophosphonate derivatives.
Sieńczyk M; Oleksyszyn J
Curr Med Chem; 2009; 16(13):1673-87. PubMed ID: 19442139
[TBL] [Abstract][Full Text] [Related]
58. Urokinase-type Plasminogen Activator-induced Mouse Back Pain Model.
Montera MA; Goins AE; Alles SRA; Westlund KN
J Vis Exp; 2023 Sep; (199):. PubMed ID: 37677033
[TBL] [Abstract][Full Text] [Related]
59. Sex differences in the acute in vivo effects of different human SP-A variants on the mouse alveolar macrophage proteome.
Phelps DS; Umstead TM; Floros J
J Proteomics; 2014 Aug; 108():427-44. PubMed ID: 24954098
[TBL] [Abstract][Full Text] [Related]
60. Mactinin, a fragment of cytoskeletal alpha-actinin, is a novel inducer of heat shock protein (Hsp)-90 mediated monocyte activation.
Luikart SD; Panoskaltsis-Mortari A; Hinkel T; Perri RT; Gupta K; Oegema TR; Gupta P
BMC Cell Biol; 2009 Aug; 10():60. PubMed ID: 19715605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
